117 related articles for article (PubMed ID: 15934897)
1. Duloxetine: pharmacoeconomic implications of an antidepressant that alleviates painful physical symptoms.
McIntyre RS; Konarski JZ
Expert Opin Pharmacother; 2005 May; 6(5):707-13. PubMed ID: 15934897
[TBL] [Abstract][Full Text] [Related]
2. Duloxetine 60 mg once-daily in the treatment of painful physical symptoms in patients with major depressive disorder.
Brannan SK; Mallinckrodt CH; Brown EB; Wohlreich MM; Watkin JG; Schatzberg AF
J Psychiatr Res; 2005 Jan; 39(1):43-53. PubMed ID: 15504423
[TBL] [Abstract][Full Text] [Related]
3. Escitalopram and duloxetine in major depressive disorder: a pharmacoeconomic comparison using UK cost data.
Wade AG; Fernández JL; François C; Hansen K; Danchenko N; Despiegel N
Pharmacoeconomics; 2008; 26(11):969-81. PubMed ID: 18850765
[TBL] [Abstract][Full Text] [Related]
4. Duloxetine does not relieve painful physical symptoms in depression: a meta-analysis.
Spielmans GI
Psychother Psychosom; 2008; 77(1):12-6. PubMed ID: 18087203
[TBL] [Abstract][Full Text] [Related]
5. The relationship between antidepressant and analgesic responses: findings from six placebo-controlled trials assessing the efficacy of duloxetine in patients with major depressive disorder.
Fishbain DA; Detke MJ; Wernicke J; Chappell AS; Kajdasz DK
Curr Med Res Opin; 2008 Nov; 24(11):3105-15. PubMed ID: 18828958
[TBL] [Abstract][Full Text] [Related]
6. Duloxetine in treatment of anxiety symptoms associated with depression.
Dunner DL; Goldstein DJ; Mallinckrodt C; Lu Y; Detke MJ
Depress Anxiety; 2003; 18(2):53-61. PubMed ID: 12964171
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of duloxetine 60 mg once daily in the treatment of pain in patients with major depressive disorder and at least moderate pain of unknown etiology: a randomized controlled trial.
Brecht S; Courtecuisse C; Debieuvre C; Croenlein J; Desaiah D; Raskin J; Petit C; Demyttenaere K
J Clin Psychiatry; 2007 Nov; 68(11):1707-16. PubMed ID: 18052564
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness and cost-effectiveness of transmural collaborative care with consultation letter (TCCCL) and duloxetine for major depressive disorder (MDD) and (sub)chronic pain in collaboration with primary care: design of a randomized placebo-controlled multi-Centre trial: TCC:PAINDIP.
de Heer EW; Dekker J; van Eck van der Sluijs JF; Beekman AT; van Marwijk HW; Holwerda TJ; Bet PM; Roth J; Hakkaart-Van Roijen L; Ringoir L; Kat F; van der Feltz-Cornelis CM
BMC Psychiatry; 2013 May; 13():147. PubMed ID: 23705849
[TBL] [Abstract][Full Text] [Related]
9. Duloxetine's role in the treatment of depression and associated painful physical symptoms.
Wohlreich MM; Watkin JG; Gonzales JS
J Clin Psychiatry; 2004 Jul; 65(7):1018-9. PubMed ID: 15291696
[No Abstract] [Full Text] [Related]
10. The effect of duloxetine on painful physical symptoms in depressed patients: do improvements in these symptoms result in higher remission rates?
Fava M; Mallinckrodt CH; Detke MJ; Watkin JG; Wohlreich MM
J Clin Psychiatry; 2004 Apr; 65(4):521-30. PubMed ID: 15119915
[TBL] [Abstract][Full Text] [Related]
11. Switching to duloxetine in selective serotonin reuptake inhibitor non- and partial-responders: effects on painful physical symptoms of depression.
Perahia DG; Quail D; Desaiah D; Montejo AL; Schatzberg AF
J Psychiatr Res; 2009 Feb; 43(5):512-8. PubMed ID: 18707693
[TBL] [Abstract][Full Text] [Related]
12. Duloxetine, 60 mg once daily, for major depressive disorder: a randomized double-blind placebo-controlled trial.
Detke MJ; Lu Y; Goldstein DJ; Hayes JR; Demitrack MA
J Clin Psychiatry; 2002 Apr; 63(4):308-15. PubMed ID: 12000204
[TBL] [Abstract][Full Text] [Related]
13. A Markov cost-utility analysis of escitalopram and duloxetine for the treatment of major depressive disorder.
Armstrong EP; Malone DC; Erder MH
Curr Med Res Opin; 2008 Apr; 24(4):1115-21. PubMed ID: 18331669
[TBL] [Abstract][Full Text] [Related]
14. Duloxetine in the treatment of major psychiatric and neuropathic disorders.
Müller N; Schennach R; Riedel M; Möller HJ
Expert Rev Neurother; 2008 Apr; 8(4):527-36. PubMed ID: 18416656
[TBL] [Abstract][Full Text] [Related]
15. Duloxetine for childhood depression with pain and dissociative symptoms.
Desarkar P; Das A; Sinha VK
Eur Child Adolesc Psychiatry; 2006 Dec; 15(8):496-9. PubMed ID: 16732464
[TBL] [Abstract][Full Text] [Related]
16. Treatment patterns associated with Duloxetine and Venlafaxine use for Major Depressive Disorder.
Ye W; Zhao Y; Robinson RL; Swindle RW
BMC Psychiatry; 2011 Jan; 11():19. PubMed ID: 21281479
[TBL] [Abstract][Full Text] [Related]
17. Effects of duloxetine treatment on brain response to painful stimulation in major depressive disorder.
López-Solà M; Pujol J; Hernández-Ribas R; Harrison BJ; Contreras-Rodríguez O; Soriano-Mas C; Deus J; Ortiz H; Menchón JM; Vallejo J; Cardoner N
Neuropsychopharmacology; 2010 Oct; 35(11):2305-17. PubMed ID: 20668437
[TBL] [Abstract][Full Text] [Related]
18. Early vs. conventional switching of antidepressants in patients with MDD and moderate to severe pain: a double-blind randomized study.
Romera I; Pérez V; Menchón JM; Schacht A; Papen R; Neuhauser D; Abbar M; Picard H; Gilaberte I
J Affect Disord; 2012 Dec; 143(1-3):47-55. PubMed ID: 22858211
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of duloxetine in painful symptoms: an analgesic or antidepressant effect?
Perahia DG; Pritchett YL; Desaiah D; Raskin J
Int Clin Psychopharmacol; 2006 Nov; 21(6):311-7. PubMed ID: 17012978
[TBL] [Abstract][Full Text] [Related]
20. Effects of duloxetine on painful physical symptoms associated with depression.
Goldstein DJ; Lu Y; Detke MJ; Hudson J; Iyengar S; Demitrack MA
Psychosomatics; 2004; 45(1):17-28. PubMed ID: 14709757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]